Literature DB >> 24185276

Variation in the Kozak sequence of WNT16 results in an increased translation and is associated with osteoporosis related parameters.

Gretl Hendrickx1, Eveline Boudin2, Igor Fijałkowski3, Torben Leo Nielsen4, Marianne Andersen5, Kim Brixen6, Wim Van Hul7.   

Abstract

The importance of WNT16 in the regulation of bone metabolism was recently confirmed by several genome-wide association studies and by a Wnt16 (Wnt16(-/-)) knockout mouse model. The aim of this study was thus to replicate and further elucidate the effect of common genetic variation in WNT16 on osteoporosis related parameters. Hereto, we performed a WNT16 candidate gene association study in a population of healthy Caucasian men from the Odense Androgen Study (OAS). Using HapMap, five tagSNPs and one multimarker test were selected for genotyping to cover most of the common genetic variation in and around WNT16 (MAF>5%). This study confirmed previously reported associations for rs3801387 and rs2707466 with bone mineral density (BMD) at several sites. Furthermore, we additionally demonstrated that rs2908007 is strongly associated with BMD at several sites in the young, elderly and complete OAS population. The observed effect of these three associated SNPs on the respective phenotypes is comparable and we can conclude that the presence of the minor allele results in an increase in BMD. Additionally, we performed re-sequencing of WNT16 on two cohorts selected from the young OAS cohort, based on their extreme BMD values. On this basis, rs55710688 was selected for an in vitro translation experiment since it is located in the Kozak sequence of WNT16a. We observed an increased translation efficiency and thus a higher amount of WNT16a for the Kozak sequence that was significantly more prevalent in the high BMD cohort. This observation is in line with the results of the Wnt16(-/-) mice. Finally, a WNT luciferase reporter assay was performed and showed no activation of the β-catenin dependent pathway by Wnt16. We did detect a dose-dependent inhibitory effect of Wnt16 on WNT1 activation of this canonical WNT pathway. Increased translation of WNT16 can thus lead to an increased inhibitory action of WNT16 on canonical WNT signaling. This statement is in contrast with the known activating effect of canonical WNT signaling on bone formation and suggests a stimulatory effect on bone metabolism via noncanonical WNT signaling. More research is required to not only confirm this hypothesis, but also to further elucidate the role of non-canonical WNT pathways in bone metabolism and the general mechanisms of interplay between the different WNT signaling pathways.
© 2013.

Entities:  

Keywords:  Association study; Bone; Kozak sequence; Osteoporosis; WNT signaling; WNT16

Mesh:

Substances:

Year:  2013        PMID: 24185276     DOI: 10.1016/j.bone.2013.10.022

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  21 in total

1.  Polymorphisms of the WNT16 gene are associated with the heel ultrasound parameter in young adults.

Authors:  M Correa-Rodríguez; J Schmidt Rio-Valle; B Rueda-Medina
Journal:  Osteoporos Int       Date:  2015-10-28       Impact factor: 4.507

Review 2.  The regulation of osteoclast differentiation by Wnt signals.

Authors:  Yasuhiro Kobayashi; Shunsuke Uehara; Masanori Koide; Naoyuki Takahashi
Journal:  Bonekey Rep       Date:  2015-07-01

3.  Bone Mass and Strength are Significantly Improved in Mice Overexpressing Human WNT16 in Osteocytes.

Authors:  Imranul Alam; Austin M Reilly; Mohammed Alkhouli; Rita L Gerard-O'Riley; Charishma Kasipathi; Dana K Oakes; Weston B Wright; Dena Acton; Amie K McQueen; Bhavmik Patel; Kyung-Eun Lim; Alexander G Robling; Michael J Econs
Journal:  Calcif Tissue Int       Date:  2016-12-24       Impact factor: 4.333

4.  Multiple analyses indicate the specific association of NR1I3, C6 and TNN with low hip BMD risk.

Authors:  Ying-Ying Han; Lan-Juan Zhao; Yong Lin; Hao He; Qing Tian; Wei Zhu; Hui Shen; Xiang-Ding Chen; Hong-Wen Deng
Journal:  J Genet Genomics       Date:  2017-05-08       Impact factor: 4.275

5.  The bone-sparing effects of estrogen and WNT16 are independent of each other.

Authors:  Sofia Movérare-Skrtic; Jianyao Wu; Petra Henning; Karin L Gustafsson; Klara Sjögren; Sara H Windahl; Antti Koskela; Juha Tuukkanen; Anna E Börjesson; Marie K Lagerquist; Ulf H Lerner; Fu-Ping Zhang; Jan-Åke Gustafsson; Matti Poutanen; Claes Ohlsson
Journal:  Proc Natl Acad Sci U S A       Date:  2015-11-16       Impact factor: 11.205

6.  Role of WNT16 in the regulation of periosteal bone formation in female mice.

Authors:  Jon E Wergedal; Chandrasekhar Kesavan; Robert Brommage; Subhashri Das; Subburaman Mohan
Journal:  Endocrinology       Date:  2014-12-18       Impact factor: 4.736

Review 7.  A new WNT on the bone: WNT16, cortical bone thickness, porosity and fractures.

Authors:  Francesca Gori; Ulf Lerner; Claes Ohlsson; Roland Baron
Journal:  Bonekey Rep       Date:  2015-05-13

8.  WNT16 induces proliferation and osteogenic differentiation of human perivascular stem cells.

Authors:  Carolyn A Meyers; Jia Shen; Amy Lu; Aaron W James
Journal:  J Orthop       Date:  2018-08-16

9.  Osteoblast-derived WNT16 represses osteoclastogenesis and prevents cortical bone fragility fractures.

Authors:  Sofia Movérare-Skrtic; Petra Henning; Xianwen Liu; Kenichi Nagano; Hiroaki Saito; Anna E Börjesson; Klara Sjögren; Sara H Windahl; Helen Farman; Bert Kindlund; Cecilia Engdahl; Antti Koskela; Fu-Ping Zhang; Emma E Eriksson; Farasat Zaman; Ann Hammarstedt; Hanna Isaksson; Marta Bally; Ali Kassem; Catharina Lindholm; Olof Sandberg; Per Aspenberg; Lars Sävendahl; Jian Q Feng; Jan Tuckermann; Juha Tuukkanen; Matti Poutanen; Roland Baron; Ulf H Lerner; Francesca Gori; Claes Ohlsson
Journal:  Nat Med       Date:  2014-10-12       Impact factor: 53.440

10.  Osteoblast-Specific Overexpression of Human WNT16 Increases Both Cortical and Trabecular Bone Mass and Structure in Mice.

Authors:  Imranul Alam; Mohammed Alkhouli; Rita L Gerard-O'Riley; Weston B Wright; Dena Acton; Amie K Gray; Bhavmik Patel; Austin M Reilly; Kyung-Eun Lim; Alexander G Robling; Michael J Econs
Journal:  Endocrinology       Date:  2015-11-19       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.